You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 108 No. 11, November 1982 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Staging of Supraglottic Cancer

Michael E. Johns, MD; Edward Farrior, MD; James C. Boyd, MD; Robert W. Cantrell, MD

Arch Otolaryngol. 1982;108(11):700-702.


Abstract

• In 1977, The American Joint Committee for Cancer Staging and End-Results Reporting (AJC) revised its 1972 staging system for supraglottic cancer of the larynx. These changes included the following: (1) reclassifying T1b carcinomas as T2 carcinomas, (2) reclassifying extension onto the medial wall of the piriform sinus or postcricoid mucosa as T3 carcinomas rather than T4 carcinomas, (3) restructuring of the N classification, and (4) changing the classification of T4 NO carcinomas from stage III to stage IV. To correlate these changes with prognosis, the cases of 178 patients with supraglottic laryngeal cancer who were treated at the University of Virginia Medical Center, Charlottesville, from 1955 to 1976 were reviewed. Each case was classified using both the 1972 and 1977 AJC TNM system. Using the 1972 staging system, the following determinations were made regarding our patient population: stage I, 43 patients; stage II, 15 patients; stage III, 116 patients; and stage IV, four patients. Using the 1977 cancer staging system, the following determinations were made: stage I, 19 patients; stage II, 37 patients; stage III, 37 patients; and stage IV, 85 patients. Six specific changes in the TNM classification system seem to be justified. However, the upstaging of T4 NO supraglottic cancers from stage III to stage IV seems to be unjustified; T4 NO cancers should be returned to the stage III grouping.

(Arch Otolaryngol 1982;108:700-702)



Author Affiliations

From the Division of Head and Neck Oncology, Departments of Otolaryngology—Head and Neck Surgery (Drs Johns, Farrior, and Cantrell), and Pathology (Dr Boyd), University of Virginia Medical Center, Charlottesville.


Footnotes

Accepted for publication July 26, 1982.

Read in part before the American Society for Head and Neck Surgery, Palm Beach, Fla, May 5, 1982.

Reprint requests to the Division of Head and Neck Oncology, Department of Otolaryngology—Head and Neck Surgery, University of Virginia Medical Center, PO Box 430, Charlottesville, VA 22908 (Dr Johns).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.